| felbamate |
| 25451-15-4 |
| Felbatol |
| 2-Phenylpropane-1,3-diyl dicarbamate |
| 2-Phenyl-1,3-propanediol dicarbamate |
| Felbamyl |
| Taloxa |
| Felbamatum |
| Felbamato |
| W-554 |
| 1,3-Propanediol, 2-phenyl-, dicarbamate |
| Felbamatum [Latin] |
| ADD-03055 |
| carbamic acid 2-phenyltrimethylene ester |
| W 554 |
| CHEBI:4995 |
| Carbamic acid, 2-phenyltrimethylene ester |
| EINECS 247-001-4 |
| UNII-X72RBB02N8 |
| NSC-759866 |
| BRN 3345236 |
| X72RBB02N8 |
| DTXSID9023041 |
| HSDB 7525 |
| 3-(carbamoyloxy)-2-phenylpropyl carbamate |
| (3-carbamoyloxy-1,1,3,3-tetradeuterio-2-phenylpropyl) carbamate |
| 2-Phenyl-1,3-propanediol 1,3-dicarbamate |
| MLS000028465 |
| DTXCID903041 |
| 4-06-00-05993 (Beilstein Handbook Reference) |
| Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester |
| Felbamatum (Latin) |
| MFCD00865296 |
| NSC 759866 |
| NCGC00015429-08 |
| W-554;ADD-03055 |
| Felbamato [Spanish] |
| SMR000058448 |
| FELBAMATE (MART.) |
| FELBAMATE [MART.] |
| FELBAMATE (USP-RS) |
| FELBAMATE [USP-RS] |
| Felbamate [USAN:INN] |
| FELBAMATE (USP MONOGRAPH) |
| FELBAMATE [USP MONOGRAPH] |
| (3-carbamoyloxy-2-phenylpropyl) carbamate |
| Felbatol (TN) |
| CAS-25451-15-4 |
| SR-01000000089 |
| ADD 03055 |
| 2 Phenyl 1,3 propanediol dicarbamate |
| Felbamate (USPINN) |
| Tocris-0869 |
| FELBAMATE [INN] |
| FELBAMATE [MI] |
| FELBAMATE [HSDB] |
| FELBAMATE [USAN] |
| Opera_ID_1738 |
| Prestwick0_000919 |
| FELBAMATE [VANDF] |
| Lopac-F-0778 |
| Biomol-NT_000203 |
| F 0778 |
| FELBAMATE [WHO-DD] |
| CHEMBL1094 |
| Lopac0_000524 |
| SCHEMBL34947 |
| MLS001077299 |
| BIDD:GT0463 |
| BPBio1_001258 |
| GTPL5473 |
| FELBAMATE [ORANGE BOOK] |
| EX-A591 |
| N03AX10 |
| HMS2093P19 |
| HMS2234H06 |
| HMS3261J09 |
| HMS3266L12 |
| HMS3370I06 |
| HMS3411P21 |
| HMS3657I11 |
| HMS3675P21 |
| HMS3715D20 |
| HMS3884E11 |
| Pharmakon1600-01505600 |
| BCP27941 |
| HY-B0184 |
| Tox21_110145 |
| Tox21_302368 |
| Tox21_500524 |
| BDBM50088430 |
| NSC759866 |
| s1330 |
| AKOS015895100 |
| Tox21_110145_1 |
| AC-8197 |
| CCG-204614 |
| CS-2068 |
| DB00949 |
| KS-1171 |
| LP00524 |
| MCULE-2661497722 |
| SDCCGSBI-0050507.P003 |
| NCGC00015429-01 |
| NCGC00015429-02 |
| NCGC00015429-03 |
| NCGC00015429-04 |
| NCGC00015429-05 |
| NCGC00015429-06 |
| NCGC00015429-07 |
| NCGC00015429-09 |
| NCGC00015429-10 |
| NCGC00015429-11 |
| NCGC00015429-14 |
| NCGC00015429-24 |
| NCGC00023092-02 |
| NCGC00023092-04 |
| NCGC00023092-05 |
| NCGC00023092-06 |
| NCGC00255275-01 |
| NCGC00261209-01 |
| SBI-0050507.P002 |
| DB-046702 |
| AE2 - Newer Anti-epileptic drug mixtures 2 |
| EU-0100524 |
| NS00010360 |
| SW197633-2 |
| (3-aminocarbonyloxy-2-phenyl-propyl) carbamate |
| C07501 |
| D00536 |
| EN300-119542 |
| AB00382985-18 |
| AB00382985_19 |
| A817858 |
| Q421301 |
| carbamic acid (3-carbamoyloxy-2-phenylpropyl) ester |
| Q-100326 |
| SR-01000000089-2 |
| SR-01000000089-4 |
| SR-01000000089-7 |
| BRD-K99107520-001-01-9 |
| BRD-K99107520-001-09-2 |
| BRD-K99107520-001-18-3 |
| Z1521554005 |
| Felbamate, United States Pharmacopeia (USP) Reference Standard |